Skip to main content

Table 3 Frequency of the severity of OABS and pH in the study groups

From: Comparison of the effect of vaginal vitamin E cream with conjugated estrogen vaginal cream on vulvovaginal atrophy and overactive bladder syndrome: a randomized controlled trial

Variable

Study groups

Pa

OR (95%CI)

OABSS

Intervention n = 36 (%)

Control n = 36 (%)

Before intervention

    

  Mild (3–5)

4 (11.1)

2 (5.6)

0.001

0.82 (0.78–1.3)

  Moderate(6–11)

17 (47.2)

33 (91.7)

  

  Severe(12 ≤)

15 (41.7)

1 (2.8)

  

After intervention

    

  None(0–3)

9 (25.0)

12 (33.3)

0.147

 

  Mild (3–5)

11 (30.6)

14 (38.9)

  

  Moderate(6–11)

12 (33.3)

10 (27.8)

  

  Severe(12 ≤)

4 (11.1)

0 (0.0)

  

  pH

    

Before intervention

    

  6.1

13 (36.1)

19 (52.8)

0.142

0.73 (0.65–1.1)

  5.6–6

18 (50.0)

16 (44.4)

  

  5.1–5.5

5 (13.9)

1 (2.8)

  

After intervention

    

  6.1

3 (8.3)

4 (11.1)

0.270

 

  5.6–6

24 (66.7)

21 (58.3)

  

  5.1–5.5

9 (25.0)

11 (30.6)

  
  1. aMantel–Haenszel test with adjusting baseline value of
  2. OABS, overactive bladder syndrome; OR, Odd Rati; CI, Confidence Interval